Nuvation Bio
NUVB
33 hedge funds and large institutions have $138M invested in Nuvation Bio in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 7 closing their positions.
243% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 7
225% more capital invested
Capital invested by funds: $42.4M → $138M (+$95.4M)
106% more funds holding
Funds holding: 16 → 33 (+17)
53.74% more ownership
Funds ownership: 25.49% → 79.23% (+54%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$26M |
| 3 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$8.68M |
| 4 |
BlackRock
New York
|
+$7.28M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GL
Governors Lane
New York
|
-$3.29M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.12M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.4M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$896K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$560K |
NUVB Hedge Fund Activity: Q4 2020 in Review
33 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q4 2020, worth a combined $138M — up 225% from $42.4M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new NUVB positions and 7 closed out — a net gain of 17 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $26M. The largest seller was Governors Lane, exiting entirely with an estimated $3.29M sold.
- 33 institutional investors held Nuvation Bio (NUVB) as of Q4 2020, up from 16 in Q3 2020.
- Funds reported $138M of Nuvation Bio stock for Q4 2020, up 225% quarter-over-quarter.
- 24 funds opened new Nuvation Bio positions in Q4 2020 and 7 closed out, a net change of +17 holders.
- The largest Nuvation Bio buyer in Q4 2020 was Citadel Advisors, an estimated $26M added.
- The largest Nuvation Bio seller in Q4 2020 was Governors Lane, an estimated $3.29M sold.
Based on aggregated 13F filings for Q4 2020.